This positive ruling for hygiene brands is a reminder that applicants must be cautious in adopting parts of registered marks, particularly if the identical part is at the beginning, as only differing the end-syllable is not a guarantee of preventing infringement.
The ASCI’s Annual Complaints Report 2023-2024 reveals crucial insights into brand advertising campaigns in India, with 98% of scrutinised ads requiring modification. Misleading ads present a challenge for law enforcement and brands must adhere to court rulings or else risk the suspension of their manufacturing licences.
In our latest round-up, we look at the adidas motion for a new Thom Browne trial being denied, an OtterBox counterfeit bust, and more.
The court notably stressed that “dietary supplements adapted for medical or dietetic use” form a sufficiently clear category within Class 5.
22 January 2024
The defence under Section 30(2)(e) can be invoked only when the defendant uses its mark for the goods for which it is registered.
05 January 2024
The trademark community has just one week left to nominate its leading in-house departments and leaders for the prestigious WTR Industry Awards 2024 and the forthcoming edition of the WTR 300.
01 December 2023
As highlighted by multiple CJEU, Supreme Court and Federal Patent Court judgments, creating a valid registration, the scope of protection, justifications for non-use of trademarks and objections to registration of infringing marks are among the most pressing issues when it comes to litigating pharmaceutical trademarks in Germany.
24 November 2023
The WTR Brand Elite fell two points in October, hitting its lowest value this year. Yet technology companies – led by Microsoft – bucked the negative trend.
17 November 2023
The decision provides some clarity on the extent to which EUTM owners may rely on the principles of the protection of legitimate expectations and legal certainty.
03 November 2023
The WTR Brand Elite fell seven points in September, hitting its lowest value since 1 January 2023. However, the brands that experienced the biggest drop in value have reason to remain optimistic.
30 October 2023
The General Court confirmed that there was no likelihood of confusion between Novartis’ mark PASCELMO and the earlier mark PASCOE, both covering Class 5 goods.
27 October 2023
A key finding was that the word ‘kind’ is not commonly used in the pharmaceutical industry and is not descriptive of pharmaceutical products.
24 October 2023
Unlock unlimited access to all WTR content
